ArticleJournal of the Endocrine Society2026
Rising trends in obesity and cancer-related mortality in the United States: a population-based analysis, 1999-2020.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rising trends in obesity and cancer-related mortality in the United States: a population-based analysis, 1999-2020.Journal of the Endocrine Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Obesity is a known risk factor for various cancers. Despite the growing prevalence of obesity in the United States, national-level trends in obesity-associated cancer mortality remain insufficiently quantified. Objective: To evaluate national trends in cancer mortality where obesity was listed as a contributing or underlying cause of death from 1999 to 2020. Methods: A retrospective cross-sectional study was conducted using publicly available mortality data from the CDC WONDER database. Adults aged 25 years and older were included if both obesity (ICD-10: E66) and cancer (ICD-10: C00-D9) were listed on their death certificates. Age-adjusted mortality rates (AAMRs) were calculated per 1 000 000 population, and Joinpoint regression was used to assess temporal trends through annual percent change (APC) and average annual percent change (AAPC). Results: A total of 33 572 obesity and cancer-related deaths were recorded. The overall AAMR rose from 3.73 in 1999 to 13.52 in 2020, with an AAPC of 5.92%. The highest mortality rates were observed in older adults, women, rural populations, and racial minorities, particularly Black and American Indian individuals. Breast, prostate, and lung cancers accounted for the greatest burden. A marked rise occurred between 2018 and 2020 across all subgroups. Conclusion: Obesity and cancer-related mortality in the United States has more than tripled over 2 decades, with notable disparities across demographic groups. These findings highlight the need for targeted public health efforts that integrate obesity prevention into cancer control strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.